IFF will launch eBoost ® GTX along with other new yeast products during 2021 including SYNERXIA ® RUBY and SYNERXIA ® SAPPHIRE.Ītul Thakrar, President of DSM Bio-based Products & Services stated, “We are excited by the potential of this agreement with IFF. It delivers low glycerol, high ethanol yield and up to 70% glucoamylase replacement. By combining the strengths of the companies’ patented and proprietary technologies, IFF’s XCELIS ® Ethanol Solutions platform will deliver new yeasts with unparalleled yield, robustness and enzyme expression.ĭSM newest yeast, eBoost ® GTX, is currently undergoing US plant trials. In addition, IFF’s R&D team will collaborate with DSM scientists to accelerate IFF’s on-going development of high-performance yeast products. Under the terms of this agreement, DSM’s eBoost ® product line will immediately become part of IFF’s XCELIS ® Ethanol Solutions platform and will be offered and supported by IFF’s experienced global commercial team. CEDAR RAPIDS, IA - IFF’s Health & Biosciences division, a world leader in sustainable biotechnology solutions, announced today that they have entered into an agreement to offer advanced yeasts for first generation ethanol production developed by DSM Bio-based Products & Services.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
January 2023
Categories |